Coherus BioSciences Announces New Employment Inducement
REDWOOD CITY, Calif., July 21, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that...
Source: globenewswire.com
Page 3 - Marek Ciszewski News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Marek Ciszewski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Marek Ciszewski Today - Breaking & Trending Today
Coherus and Superior Biologics Announce National
First formal distribution agreement for YUSIMRY™, a biosimilar of Humira®, at $995 per carton (two 40 mg/0.8 mL autoinjectors) representing a discount of...
Source: globenewswire.com
Coherus and Superior Biologics Announce National Distribution Agreement for YUSIMRY™
YUSIMRY™ (adalimumab-aqvh) product image REDWOOD CITY, Calif., July 13, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) and…
Source: sina.com.hk
Coherus Launches YUSIMRY, a Biosimilar of Humira, at $995 per Carton in U.S.
REDWOOD CITY - Coherus BioSciences, Inc. , today announced that YUSIMRY is now available for commercial sale in the United States at a list price of $995 per carton for two 40 mg/0.8 mL...
Source: marketscreener.com
Coherus Launches YUSIMRY™, a Biosimilar of Humira®, at $995 per Carton in U.S.
–$995 per carton represents a discount of more than 85% compared to Humira® – – YUSIMRY™ meets high unmet need by providing patients, employers, physicians and payers...
Source: marketscreener.com